About The Treatment
SPRAVATO® is the first FDA-approved nasal spray medication, taken with an oral antidepressant, for treatment-resistant depression in adults. The approval of this drug by the FDA is considered to be one of the most significant advances in mental health in the last 30 years, as now patients who have failed two or more antidepressants have a safe, fast-acting, solution that is covered by most insurance.
MWI Health is an approved Spravato® center. Interested in learning more? Call to schedule an evaluation at 605-573-2000 or click the button below to fill out our patient form.
